PARENTAL ALERT: Adderall abuse increasing among teens
Parents should be aware of their children’s study habits. A new report by the University of Michigan found a link between studying and the abuse of ADHD medications Adderall and Ritalin. “The study associates using both stimulant and non-stimulant ADHD medications with greater probability of experimenting with cocaine, methamphetamine, and other prescription stimulants.” Prescribed to treat symptoms […]
Addiction Recovery Care Welcomes Brad Hall as Vice President of Strategic Initiatives
Addiction Recovery Care (ARC), a leading provider of addiction treatment programs throughout Kentucky, is expanding its team with a new Vice President of Strategic Initiatives. Brad Hall brings over 25 years in strategic operations, leadership and external affairs to the executive team. Most recently, Hall served as Vice President of Strategic Operations for Boa Vida […]
Spike in overdoses reported across Kentucky
First responders across Kentucky have responded to a spike in overdose incidents in the last 24 hours. According to tracking, several overdoses in Madison and Laurel Counties have prompted health officials to request a spike alert. It is unclear what substances are to blame for the spike or if Fentanyl is an underlying factor. […]
ARC names Sarah Adkins Site Administrator of Yellow Banks Facility
As Addiction Recovery Care (ARC) moves forward in opening Yellow Banks Recovery Center in Owensboro, the organization has hired Sarah Adkins as the center’s Administrator. Adkins brings more than a decade of experience in healthcare leadership. Most recently, Adkins served as Director of Owensboro Regional Recovery, a Recovery Kentucky program. She serves on various local […]
ARC Announces Bellefonte Hospital and Recovery Center CEO
As Addiction Recovery Care (ARC) moves forward in opening Bellefonte Hospital and Recovery Center in Greenup County, the company has hired Johnathan Frazier as the center’s Chief Executive Officer. Frazier brings more than 15 years of experience in healthcare executive leadership. Most recently, Frazier served as Market CEO for NeuroPsychiatric Hospitals, a network of inpatient […]
“Just Say No was not enough”
Since 1983 the D.A.R.E program has helped teach school-age children about the dangers of drugs. You’ve seen the shirts and heard the slogan, “Just Say No to Drugs.” However, the organization’s message is changing, and one mother believes it could have saved her son’s life. “My son passed away on Sept. 16, 2020, from fentanyl […]
Kristina Arnette Joins Addiction Recovery Care as Senior Vice President of Finance
As Addiction Recovery Care (ARC) continues to expand its operations throughout Kentucky and the surrounding region, the company has hired Kristina Arnette as its Senior Vice President of Finance. Arnette brings more than 25 years in accounting and finance and 15 years in health care. Most recently, Arnette served as Senior Vice President of Finance […]
ARC receives Eastern Kentucky Recovery award presented by Operation UNITE at 2023 SOAR Gala
Previous Next Addiction Recovery Care was proud to accept the Eastern Kentucky Recovery award during the first annual Shaping Our Appalachian Region (SOAR) Gala. The award is presented to an individual, group or organization who works on the frontlines of Kentucky’s addiction crisis. The award is designed to recognize efforts of training, employment, the establishing […]
Drug overdose deaths decline in Kentucky for the first time in 4 years
For the first year since 2018, drug overdoses in Kentucky have declined. According to the Kentucky Injury Prevention and Research Center (KIPRC), 2,127 Kentuckians died from a drug overdose in 2022 compared with 2,257 in 2021. In a press release, Gov. Beshear noted, “While we find hope in the decline in drug overdose deaths, this […]
Addiction Recovery Care Echoes Warnings on Xylazine and Fentanyl
Federal officials are sounding the alarm on xylazine, also known as “tranq,” which is making fentanyl use even more dangerous and deadly. On April 12, 2023, the Biden administration designated fentanyl combined with xylazine as an emerging threat in the U.S. Xylazine is a non-opioid tranquilizer approved by the FDA for veterinary but not human […]
